Difficulty: Medium
Average Score: 74%
Practice
A client with a diagnosis of acute myocardial infarction (MI) is receiving thrombolytic therapy. The nurse monitors the client for which potential complication associated with this therapy?
Correct answer
B
Rationale
In the context of a client receiving thrombolytic therapy for acute myocardial infarction (MI), monitoring for bleeding is crucial as the correct answer. Thrombolytic agents work by breaking down blood clots to improve blood flow, but this action also increases the risk of bleeding. Patients on thrombolytic therapy are at higher risk of developing bleeding complications, including intracranial hemorrhage, gastrointestinal bleeding, or bleeding at the site of vascular access.
Option A, hypertension, is not a direct complication associated with thrombolytic therapy. While hypertension may be a risk factor for MI, it is not a common complication of thrombolytic therapy itself.
Option C, hyperkalemia, is not a typical complication of thrombolytic therapy. Hyperkalemia is more commonly associated with conditions like kidney failure or certain medications, rather than thrombolytic therapy.
Option D, hypoglycemia, is also not a common complication of thrombolytic therapy. Hypoglycemia is more likely to occur in patients receiving medications like insulin or oral hypoglycemic agents.
In an educational context, understanding the potential complications of thrombolytic therapy is crucial for nurses caring for patients with MI. By knowing the risks associated with this treatment, nurses can implement appropriate monitoring, interventions, and patient education to promote positive outcomes and minimize complications.
Option A, hypertension, is not a direct complication associated with thrombolytic therapy. While hypertension may be a risk factor for MI, it is not a common complication of thrombolytic therapy itself.
Option C, hyperkalemia, is not a typical complication of thrombolytic therapy. Hyperkalemia is more commonly associated with conditions like kidney failure or certain medications, rather than thrombolytic therapy.
Option D, hypoglycemia, is also not a common complication of thrombolytic therapy. Hypoglycemia is more likely to occur in patients receiving medications like insulin or oral hypoglycemic agents.
In an educational context, understanding the potential complications of thrombolytic therapy is crucial for nurses caring for patients with MI. By knowing the risks associated with this treatment, nurses can implement appropriate monitoring, interventions, and patient education to promote positive outcomes and minimize complications.